Digital Health Pass Prevention Act or DHPPA This bill prohibits federal funding of programs that use digital health passes. A digital health pass is any standardized documentation that certifies an individual's vaccination history to a third party, excluding documentation issued for the purposes of health records.
Patient Access to Urgent-Use Pharmacy Compounding Act of 2021 This bill relaxes certain requirements for compounding drugs that are facing shortages. Drug compounding is the process of mixing or otherwise altering drugs to create a medication. Currently, the Food and Drug Administration (FDA) allows for drug compounding subject to certain requirements. Generally a licensed pharmacist or physician not registered with the FDA may only compound drugs in limited quantities for prescriptions for a specific individual patient. On the other hand, an FDA-registered outsourcing facility may compound drugs in bulk for use in medical facilities but is subject to additional requirements. This bill allows a compounder not registered with the FDA to compound drugs in limited quantities for urgent medical need not involving a specific patient if, among other things, (1) the prescriber certifies that they are unable to obtain, despite reasonable attempts, certain related drugs with the same active ingredient and route of administration; (2) the compounded drug meets certain labeling requirements, including an indication that the compounded drug is provided only for urgent administration to a patient; and (3) the compounder requests and maintains certain records about patients receiving the compounded drug. Furthermore, a restriction against an unregistered compounder regularly compounding (or compounding inordinate amounts of) what is essentially a copy of a commercially available drug shall not apply if the drug is on a shortage list maintained by the FDA or the American Society of Hospital Pharmacists.
This bill prohibits the Department of the Interior, during 2021, from using the COVID-19 pandemic or any issue related to the pandemic as a basis for restricting or limiting outdoor recreational use of land or water administered by the National Park Service.
Armed Forces Transgender Dependent Protection Act This bill expands the policy of the Office of Special Needs within the Department of Defense to address transgender dependents. Specifically, the bill codifies the definition of a medical or educational special need to include gender dysphoria. Under the bill, the policy of the office must prohibit the assignment of a military family with special needs to a permanent duty location where the law restricts medically necessary treatment for a medical or educational special need. A member who is serving at a location when such a law is established may elect to be reassigned.
Improving Access to Medicare Coverage Act of 2021 This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services.
Clean Water Standards for PFAS Act of 2021 This bill directs the Environmental Protection Agency (EPA) to develop requirements and incentives to limit the discharge of perfluoroalkyl and polyfluoroalkyl substances (PFAS) into certain waters of the United States. PFAS are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing. Within two years, the EPA must publish water quality criteria for each measurable perfluoroalkyl substance, polyfluoroalkyl substance, and class of PFAS. The water quality criteria must determine how much of these substances can be present in water before it is likely to harm human health. Within four years, the EPA must publish a final rule that establishes, for each priority industry category specified in the bill, effluent limitations guidelines and standards for the discharge of each measurable perfluoroalkyl substance, polyfluoroalkyl substance, and class of PFAS. Under the Clean Water Act, effluent limitations restrict the quantities, rates, and concentrations of chemical, physical, biological, and other constituents which are discharged from point sources (e.g., a discernible source such as a pipe) into navigable waters, the ocean, or other specified waters. In addition, the EPA must award grants to owners and operators of publicly owned treatment works for implementing the effluent limitations guidelines and standards.
Surface Transportation Research and Development Act of 202 1 This bill addresses provisions related to surface transportation research, development, and deployment programs of the Department of Transportation (DOT). Among other provisions, the bill reauthorizes through FY2026 DOT highway research and development programs, including highway safety, technology and innovation deployment, training and education, and intelligent transportation systems; sets forth a program to provide awards to institutions of higher education or nonprofit research organizations to establish regional road weather research and development centers; reauthorizes through FY2026 the University Transportation Centers Program, the Bureau of Transportation Statistics, the public transportation research and development program, the National Cooperative Rail Research Program, the hazardous materials research and development program, and the National Cooperative Freight Transportation Research Program; establishes Centers of Excellence to advance research and development that improves the resilience of regions of the United States to natural disasters, extreme weather, and the effects of climate change on modal and multimodal transportation and infrastructure; directs DOT to carry out and publish the results of a study for the purpose of informing land use and transportation planning for accessible health, food, education, and other essential services and activities; and requires DOT to establish a multimodal national cooperative freight transportation research program, a Heavy Freight Automated Trucking Research Initiative, and an Advanced Transportation Research and Innovation Program.
Algorithmic Justice and Online Platform Transparency Act This bill establishes requirements for certain commercial online platforms (e.g., social media sites) that withhold or promote content through algorithms and related computational processes that use personal information. The platforms must make disclosures about their collection and use of personal information and their content moderation practices; retain specified records that describe how the algorithms use personal information and assess whether the algorithms produce disparate outcomes based on race and other demographic factors in terms of access to housing, employment, financial services, and related matters; employ algorithms safely and effectively; and allow users to access and transfer their personal information. If a platform uses algorithms to publish or sell advertising, it must maintain a library of the advertisements. The Federal Trade Commission must also adopt rules concerning deceptive advertising. A platform's chief executive officer or other senior officer must certify compliance with disclosure requirements. Additionally, platforms may not (1) employ algorithms or other design features that result in discrimination or similar harms based on demographic or biometric factors, or (2) process information such that it impairs voting rights. Further, users of a platform may not violate civil rights laws using the platform's algorithms. The bill prohibits waivers or other methods that limit rights under the bill; provides whistleblower protections for individuals who report violations; and authorizes enforcement by specified federal agencies, states, and private individuals. The bill also provides funding for an interagency task force to study the discriminatory use of personal information by platforms' algorithms.
LymeX Authorization Act This bill authorizes the Department of Health and Human Services to carry out prize competitions to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease. Lyme disease is a bacterial infection carried by ticks that can spread to joints, the heart, and the nervous system.
Digital Taxonomy Act This bill requires the Federal Trade Commission to report on its efforts to address unfair or deceptive trade practices related to digital tokens (i.e., transferable units of a digital currency).
Protecting Americans from the Risks of Keyless Ignition Technology Act or the PARK IT Act This bill directs the Department of Transportation (DOT) to finalize regulations relating to automatic shutoff systems for motor vehicles and standards to prevent the movement of vehicles in specific situations. Specifically, DOT must require manufacturers to install technology in each motor vehicle with a keyless ignition device and an internal combustion engine to automatically shut off the motor vehicle after the motor vehicle has idled for a period necessary to prevent carbon monoxide poisoning. It must also require the technology in each motor vehicle with a keyless ignition device and automatic transmission to prevent movement (i.e., rollaway) of the motor vehicle if (1) the transmission of the motor vehicle is not in the park setting, (2) the motor vehicle does not exceed the speed determined by DOT, (3) the door for the operator of the motor vehicle is open, (4) the seat belt of the operator of the motor vehicle is unbuckled, and (5) the service brake of the motor vehicle is not engaged.
Blockchain Innovation Act This bill requires the Department of Commerce to consult with the Federal Trade Commission and other relevant agencies to study potential applications of blockchain technology (i.e., the technology that supports digital currencies such as Bitcoin), including the use of such technology to address fraud and other unfair or deceptive practices.
